Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Nick Norwitz: [0:53:13] N-O-R-W-I-T-Z is my last name
Research applications span muscle cell biology, tissue regeneration models, and investigations into the IGF-1/PI3K/Akt/mTOR signalling cascade
Zepbound (tirzepatide) mimics two gut hormones GLP-1 and glucose-dependent insulinotropic polypeptide (GIP)
Another study the review mentioned tested a GLP-1 medication on mice with the neurodegenerative eye disease glaucoma, and found a reduction in astrocyte transformation and retinal ganglion cell death. With microglia, the review shows that some studies believe GLP-1 receptor signaling can reverse inflammation
Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial. The New England Journal of Medicine
Key considerations include: The safety profile of weight loss injections in patients with dyslipidaemia Potential interactions with lipid-lowering medications The impact of weight loss itself on cholesterol levels Individual cardiovascular risk assessment Clinical evidence suggests that GLP-1 receptor agonists may have beneficial effects on lipid profiles beyond their primary weight loss action
